MYRIAD GENETICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.77 USD | +3.34% |
|
+0.32% | +29.26% |
| 27/06 | Scotiabank Initiates Myriad Genetics at Sector Outperform | MT |
| 12/06 | Transcript : Myriad Genetics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 03:20 PM |
Presenter SpeechCasey Woodring (Analysts)Hi, everyone, welcome to the 2021 JPMorgan Healthcare...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has specialized products, capabilities, and expertise: Oncology, Women's Health and Mental Health. In oncology, it offers testing for patients who have cancer and companion diagnostic tests that work with corresponding drugs and treatments. It also offers the SneakPeek Early Gender DNA Test which can reveal a baby's gender as early as six weeks into pregnancy. The Companyâs testing products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight, Prequel, Precis Tumor Test, Precise Liquid Test, SneakPeek and GeneSight.
Calendar
01/08/2024
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
23.97
USD
Average target price
25.42
USD
Spread / Average Target
+6.04%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.26% | 2.17B | |
| -10.83% | 11.36B | |
| -19.13% | 7.17B | |
| +27.39% | 5.55B | |
| +3.47% | 5.33B | |
| -20.49% | 3.65B | |
| +6.88% | 2.59B | |
| -66.66% | 2.23B | |
| -14.18% | 2.2B | |
| -19.95% | 1.58B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Transcript : Myriad Genetics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-11-2021 11
